Evidence Library
Filter by drug, type, year, and open access.
Showing 51–89 of 89 results
- Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis — BMJ (2020)• Drug: disulfiramOpen accessDOIPMIDPMCID
- Iloperidone for schizophrenia: updated systematic review and meta-analysis — International Journal of Neuropsychopharmacology (2019)• Drug: iloperidoneDOIPMID
- Comparative efficacy of antidepressants: network meta-analysis including bupropion — The Lancet (2018)• Drug: bupropionDOIPMID
- Risperidone efficacy in schizophrenia: meta‑analysis — Meta‑analysis (2018)• Drug: risperidone
- Comparative efficacy of antidepressants: network meta-analysis including citalopram — The Lancet (2018)• Drug: citalopramDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: methylphenidateDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: dexmethylphenidateDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: amphetamine-dextroamphetamineDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: lisdexamfetamineDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: atomoxetineDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: guanfacine-erDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: clonidineDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: clonidine-erDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: guanfacineDOIPMID
- Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: systematic review and network meta-analysis — Lancet Psychiatry (2018)• Drug: viloxazineDOIPMID
- Nicotine replacement therapy versus control for smoking cessation — Cochrane Database of Systematic Reviews (2018)• Drug: nicotineOpen accessDOIPMIDPMCID
- Benzodiazepines for catatonia: systematic review and meta-analysis — Schizophrenia Research (2018)• Drug: lorazepamDOI
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder — The Lancet (2018)• Drug: trazodoneDOIPMID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Buprenorphine for managing opioid withdrawal — Cochrane Database of Systematic Reviews (2017)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: methadoneOpen accessDOIPMIDPMCID
- Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis — Journal of Psychopharmacology (2016)• Drug: propranololDOI
- Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials — International Journal of Neuropsychopharmacology (2016)• Drug: risperidone-microspheresOpen accessDOIPMIDPMCID
- Alpha₂-adrenergic agonists for the management of opioid withdrawal — Cochrane Database of Systematic Reviews (2016)• Drug: lofexidineOpen accessDOIPMIDPMCID
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: naltrexoneDOIPMID
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence — Cochrane Database of Systematic Reviews (2014)• Drug: buprenorphineOpen accessDOIPMIDPMCID
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence — Cochrane Database of Systematic Reviews (2014)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: acamprosateDOIPMID
- Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis — PLOS ONE (2014)• Drug: disulfiramOpen accessDOIPMIDPMCID
- Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis — JAMA (2014)• Drug: disulfiramDOIPMID
- Meta-analysis: melatonin for the treatment of primary sleep disorders — PloS one (2013)• Drug: melatoninOpen accessDOIPMIDPMCID
- Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials — Journal of Clinical Psychiatry (2013)• Drug: modafinilDOI
- A Meta-Analysis of the Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder — The Canadian Journal of Psychiatry (2011)• Drug: pregabalinDOI
- Oral naltrexone maintenance treatment for opioid dependence — Cochrane Database of Systematic Reviews (2011)• Drug: naltrexoneOpen accessDOIPMIDPMCID
- Acamprosate for alcohol dependence — Cochrane Database of Systematic Reviews (2010)• Drug: acamprosateOpen accessDOIPMIDPMCID
- Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis — Journal of Affective Disorders (2010)• Drug: valproate-divalproexDOI
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence — Cochrane Database of Systematic Reviews (2009)• Drug: methadoneOpen accessDOIPMIDPMCID
- Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials — Journal of Psychopharmacology (2007)• Drug: diazepamDOIPMID